- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on CD30-Positive Gray Zone Lymphoma in United Kingdom
Total 2340 results
-
St George's, University of LondonNovartis Vaccines; Statens Serum Institut; European UnionTerminatedTuberculosisUnited Kingdom
-
University of OxfordCompleted
-
Mayo ClinicNational Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Splenic Marginal Zone Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Cutaneous B-cell Non-Hodgkin Lymphoma | Small Lymphocytic Lymphoma | Adult Grade III Lymphomatoid... and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingPlasmablastic Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Refractory High Grade B-Cell... and other conditionsUnited States
-
University of OxfordCompleted
-
University of OxfordWellcome Trust; St George's, University of LondonCompleted
-
University of OxfordCompletedTuberculosisUnited Kingdom
-
University of OxfordCompleted
-
Gilead SciencesCompletedFollicular Lymphoma | Marginal Zone Lymphoma | Lymphoplasmacytic Lymphoma | Small Lymphocytic LymphomaUnited States, United Kingdom, Italy, Germany, Poland, France
-
University of MiamiAstraZenecaTerminatedMarginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B Cell Lymphoma | Small Lymphocytic LeukemiaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States
-
King's College Hospital NHS TrustTerminatedLymphoma, Non-Hodgkin | Myelodysplastic Syndromes | Leukemia, Myeloid, Acute | Hodgkin Disease | Chronic Lymphocytic Leukemia | Leukemia, Lymphoblastic, AcuteUnited Kingdom
-
New York Medical CollegeRoswell Park Cancer InstituteRecruitingDiffuse Large B-Cell Lymphoma | Burkitt Lymphoma | Non-Hodgkin Lymphoma | Primary Mediastinal B-cell Lymphoma | CD20+ Lymphoblastic Lymphoma | Follicular Lymphoma, Grade IIIUnited States
-
Children's Hospital Medical Center, CincinnatiJazz PharmaceuticalsCompletedAcute Myeloid Leukemia | Hodgkin Lymphoma | Burkitt Lymphoma | Acute Lymphoblastic Leukemia | Lymphoblastic Lymphoma | Anaplastic Large Cell Lymphoma | Diffuse Large Cell Lymphoma | Gray Zone LymphomaUnited States
-
International Extranodal Lymphoma Study Group (IELSG)CompletedLymphoma, Mucosa-Associated Lymphoid TissueUnited Kingdom, France, Italy, Switzerland, Spain, Belgium
-
Statens Serum InstitutCompleted
-
University of BirminghamHeart of England NHS TrustCompleted
-
GlaxoSmithKlineRecruitingTuberculosisUnited Kingdom, Netherlands
-
Indiana University School of MedicineCompletedLymphoma, Non-Hodgkin | Leukemia, Myeloid, Acute | Acute Lymphoblastic Leukemia | Myelodysplasia | Leukemia, Myelogenous, ChronicUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States
-
Joseph TuscanoNational Cancer Institute (NCI); CelgeneActive, not recruitingRecurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Refractory Chronic Lymphocytic Leukemia | Refractory Hairy Cell Leukemia | Refractory Mantle Cell Lymphoma | Recurrent... and other conditionsUnited States
-
University College, LondonPublic Health EnglandCompletedTuberculosisUnited Kingdom
-
Queen Mary University of LondonUniversity College, London; Public Health EnglandCompletedLatent TuberculosisUnited Kingdom
-
National Cancer Institute (NCI)TerminatedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Splenic Marginal Zone Lymphoma | Waldenström Macroglobulinemia | Testicular Lymphoma | Contiguous Stage II Adult Diffuse Large Cell Lymphoma | Noncontiguous Stage II Adult Diffuse... and other conditionsUnited States
-
Masonic Cancer Center, University of MinnesotaTerminatedFollicular Lymphoma | Myelodysplastic Syndromes | Multiple Myeloma | Hodgkin Lymphoma | Burkitt Lymphoma | Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Lymphoplasmacytic Lymphoma | Acute Myelogenous Leukemia | Mantle-Cell Lymphoma | Chronic Myelogenous Leukemia | Prolymphocytic Leukemia | Small... and other conditionsUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Marginal Zone Lymphoma | Splenic... and other conditionsUnited States
-
St George's, University of LondonUnknownTuberculosis (TB)United Kingdom
-
Helen ReynoldsLiverpool University Hospitals NHS Foundation TrustCompleted
-
Minervax ApSSimbec ResearchCompleted
-
BeiGeneCompletedMarginal Zone Lymphoma | MZLChina, Australia, Italy, France, New Zealand, Czechia, United Kingdom, United States, Korea, Republic of
-
ImmunoBiology LimitedSimbec Research; ORION Clinical Services; Oxford Therapeutics Consulting LimitedCompletedPneumococcal InfectionUnited Kingdom
-
Ohio State University Comprehensive Cancer CenterMillennium Pharmaceuticals, Inc.TerminatedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade... and other conditionsUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedFollicular Lymphoma | Diffuse Large B-Cell Lymphoma | Hodgkin Lymphoma | Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Acute Leukemia | Myelodysplastic Syndrome | Refractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Myeloproliferative... and other conditionsUnited States
-
Massachusetts General HospitalTG TherapeuticsTerminatedLymphoma | Follicular Lymphoma | Marginal Zone Lymphoma | Follicular Lymphoma, Grade 1 | Follicular Lymphoma Grade IIIa | Marginal Zone B Cell Lymphoma | Follicular Lymphoma Grade 2United States
-
Statens Serum InstitutCompleted
-
Public Health EnglandInstitute of Child Health; National Institute of Biological Standards and ControlCompletedPneumococcal Infections | Meningococcal InfectionsUnited Kingdom
-
Pharmacyclics LLC.Janssen Research & Development, LLCCompletedB-cell Lymphoma | Marginal Zone LymphomaUnited States, Belgium, France, Germany, United Kingdom
-
University of MiamiTerminatedLymphoma | Follicular Lymphoma | Marginal Zone LymphomaUnited States
-
Fred Hutchinson Cancer Centermedac GmbHRecruitingAcute Myeloid Leukemia | Hodgkin Lymphoma | Chronic Myelomonocytic Leukemia | Burkitt Lymphoma | Acute Lymphoblastic Leukemia | Lymphoblastic Lymphoma | Mantle Cell Lymphoma | Lymphoplasmacytic Lymphoma | Anaplastic Large Cell Lymphoma | Acute Leukemia | Myelodysplastic Syndrome | Prolymphocytic Leukemia | Refractory... and other conditionsUnited States
-
University of OxfordImaxioCompletedTuberculosis (TB)United Kingdom
-
Imperial College Healthcare NHS TrustBarts & The London NHS Trust; Royal Free Hospital NHS Foundation Trust; University... and other collaboratorsActive, not recruiting
-
National Cancer Institute (NCI)CompletedRecurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma and other conditionsUnited States
-
Queen Mary University of LondonImperial College London; University College, London; City, University of LondonActive, not recruiting
-
Reid Merryman, MDGenentech, Inc.RecruitingFollicular Lymphoma | Marginal Zone Lymphoma | Indolent Non-hodgkin LymphomaUnited States
-
NeuTec PharmaCompleted
-
Duke UniversityCelgeneTerminatedFollicular Lymphoma | Marginal Zone LymphomaUnited States
-
University of OxfordUniversity of BirminghamCompletedTuberculosisUnited Kingdom
-
University of OxfordCompletedTuberculosisUnited Kingdom
-
University of OxfordUniversity of Southampton; University of Bristol; University of LondonCompleted
-
Louisiana State University Health Sciences Center...Millennium Pharmaceuticals, Inc.WithdrawnFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone LymphomaUnited States